The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Nutraceuticals in cognitive impairment and Alzheimer’s disease
|
|---|---|
| Published in |
Frontiers in Pharmacology, June 2014
|
| DOI | 10.3389/fphar.2014.00147 |
| Pubmed ID | |
| Authors |
P. Mecocci, C. Tinarelli, R. J. Schulz, M. C. Polidori |
| Abstract |
Several chemical substances belonging to classes of natural dietary origin display protective properties against some age-related diseases including neurodegenerative ones, particularly Alzheimer's disease (AD). These compounds, known as nutraceuticals, differ structurally, act therefore at different biochemical and metabolic levels and have shown different types of neuroprotective properties. The aim of this review is to summarize data from observational studies, clinical trials, and randomized clinical trials (RCTs) in humans on the effects of selected nutraceuticals against age-related cognitive impairment and dementia. We report results from studies on flavonoids, some vitamins and other natural substances that have been studied in AD and that might be beneficial for the maintenance of a good cognitive performance. Due to the substantial lack of high-level evidence studies there is no possibility for recommendation of nutraceuticals in dementia-related therapeutic guidelines. Nevertheless, the strong potential for their neuroprotective action warrants further studies in the field. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 50% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
| Scientists | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Czechia | 1 | <1% |
| Unknown | 168 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 28 | 16% |
| Student > Bachelor | 23 | 13% |
| Student > Master | 19 | 11% |
| Researcher | 16 | 9% |
| Student > Postgraduate | 11 | 6% |
| Other | 32 | 19% |
| Unknown | 42 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 16% |
| Agricultural and Biological Sciences | 23 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 12% |
| Biochemistry, Genetics and Molecular Biology | 17 | 10% |
| Neuroscience | 10 | 6% |
| Other | 26 | 15% |
| Unknown | 47 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 August 2024.
All research outputs
#2,601,329
of 25,890,819 outputs
Outputs from Frontiers in Pharmacology
#1,104
of 20,039 outputs
Outputs of similar age
#25,054
of 244,524 outputs
Outputs of similar age from Frontiers in Pharmacology
#8
of 74 outputs
Altmetric has tracked 25,890,819 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,039 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,524 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.